Letter to the Editor
Comment on “Cellular and molecular aspects of diabetic nephropathy; the role of VEGF-A”
Comentario a “Cellular and molecular aspects of diabetic nephropathy; the role of VEGF-A”
Erol Arslan
, Adem Aydın, Şeref Demirbaş, Kenan Sağlam
Autor para correspondencia
Department of Internal Medicine, Gülhane Military Medical Academy, Ankara, Turkey
Leído
7739
Vecesse ha leído el artículo
2631
Total PDF
5108
Total HTML
Compartir estadísticas
array:25 [ "pii" => "S0211699516301114" "issn" => "02116995" "doi" => "10.1016/j.nefro.2016.06.010" "estado" => "S300" "fechaPublicacion" => "2016-11-01" "aid" => "246" "copyright" => "Sociedad Española de Nefrología" "copyrightAnyo" => "2016" "documento" => "simple-article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "cor" "cita" => "Nefrologia. 2016;36:705" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 3733 "formatos" => array:3 [ "EPUB" => 406 "HTML" => 2530 "PDF" => 797 ] ] "Traduccion" => array:1 [ "en" => array:20 [ "pii" => "S2013251416301304" "issn" => "20132514" "doi" => "10.1016/j.nefroe.2016.12.003" "estado" => "S300" "fechaPublicacion" => "2016-11-01" "aid" => "246" "copyright" => "Sociedad Española de Nefrología" "documento" => "simple-article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "cor" "cita" => "Nefrologia (English Version). 2016;36:705" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 2621 "formatos" => array:3 [ "EPUB" => 342 "HTML" => 1792 "PDF" => 487 ] ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Comment on “Cellular and molecular aspects of diabetic nephropathy; the role of VEGF-A”" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "705" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Comentario a “Cellular and molecular aspects of diabetic nephropathy; the role of VEGF-A”" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Erol Arslan, Adem Aydın, Şeref Demirbaş, Kenan Sağlam" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Erol" "apellidos" => "Arslan" ] 1 => array:2 [ "nombre" => "Adem" "apellidos" => "Aydın" ] 2 => array:2 [ "nombre" => "Şeref" "apellidos" => "Demirbaş" ] 3 => array:2 [ "nombre" => "Kenan" "apellidos" => "Sağlam" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S0211699516301114" "doi" => "10.1016/j.nefro.2016.06.010" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699516301114?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251416301304?idApp=UINPBA000064" "url" => "/20132514/0000003600000006/v1_201702210030/S2013251416301304/v1_201702210030/en/main.assets" ] ] "itemSiguiente" => array:20 [ "pii" => "S0211699516301138" "issn" => "02116995" "doi" => "10.1016/j.nefro.2016.08.001" "estado" => "S300" "fechaPublicacion" => "2016-11-01" "aid" => "248" "copyright" => "Sociedad Española de Nefrología" "documento" => "simple-article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "cor" "cita" => "Nefrologia. 2016;36:706-7" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 4837 "formatos" => array:3 [ "EPUB" => 322 "HTML" => 3728 "PDF" => 787 ] ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Carta al Director</span>" "titulo" => "Respuesta a la carta al editor referida a «Mecanismos celulares y moleculares de la nefropatía diabética, rol del VEGF-A»" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "706" "paginaFinal" => "707" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Reply to letter to editor comment on «Cellular and molecular aspects of diabetic nephropathy; the role of VEGF-A»" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Delma Veron, Alda Tufro" "autores" => array:2 [ 0 => array:2 [ "nombre" => "Delma" "apellidos" => "Veron" ] 1 => array:2 [ "nombre" => "Alda" "apellidos" => "Tufro" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2013251417300135" "doi" => "10.1016/j.nefroe.2017.01.010" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251417300135?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699516301138?idApp=UINPBA000064" "url" => "/02116995/0000003600000006/v1_201611240148/S0211699516301138/v1_201611240148/es/main.assets" ] "itemAnterior" => array:20 [ "pii" => "S0211699516300868" "issn" => "02116995" "doi" => "10.1016/j.nefro.2016.05.022" "estado" => "S300" "fechaPublicacion" => "2016-11-01" "aid" => "235" "copyright" => "Sociedad Española de Nefrología" "documento" => "simple-article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "crp" "cita" => "Nefrologia. 2016;36:701-4" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 5503 "formatos" => array:3 [ "EPUB" => 374 "HTML" => 4341 "PDF" => 788 ] ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Case report</span>" "titulo" => "Failed ABO incompatible high titers kidney transplant using bortezomib. Case report" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "701" "paginaFinal" => "704" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Fracaso en el uso de bortezomib en el trasplante ABO incompatible con titulos altos. Reporte de un caso" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1475 "Ancho" => 2167 "Tamanyo" => 203840 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Desensitization protocol, including the three phases of consecutive treatment. RTX, rituximab; BTZ, bortezomib; PE, plasma exchange; IVIG intravenous immunoglobulins.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Erika De Sousa-Amorim, Ignacio Revuelta, Fritz Diekmann, Joan Cid, Miquel Lozano, Federic Oppenheimer" "autores" => array:6 [ 0 => array:2 [ "nombre" => "Erika" "apellidos" => "De Sousa-Amorim" ] 1 => array:2 [ "nombre" => "Ignacio" "apellidos" => "Revuelta" ] 2 => array:2 [ "nombre" => "Fritz" "apellidos" => "Diekmann" ] 3 => array:2 [ "nombre" => "Joan" "apellidos" => "Cid" ] 4 => array:2 [ "nombre" => "Miquel" "apellidos" => "Lozano" ] 5 => array:2 [ "nombre" => "Federic" "apellidos" => "Oppenheimer" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S201325141630133X" "doi" => "10.1016/j.nefroe.2016.05.009" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S201325141630133X?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699516300868?idApp=UINPBA000064" "url" => "/02116995/0000003600000006/v1_201611240148/S0211699516300868/v1_201611240148/en/main.assets" ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Comment on “Cellular and molecular aspects of diabetic nephropathy; the role of VEGF-A”" "tieneTextoCompleto" => true "saludo" => "Dear Editor," "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "705" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Erol Arslan, Adem Aydın, Şeref Demirbaş, Kenan Sağlam" "autores" => array:4 [ 0 => array:4 [ "nombre" => "Erol" "apellidos" => "Arslan" "email" => array:1 [ 0 => "earslan89@yahoo.com" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:2 [ "nombre" => "Adem" "apellidos" => "Aydın" ] 2 => array:2 [ "nombre" => "Şeref" "apellidos" => "Demirbaş" ] 3 => array:2 [ "nombre" => "Kenan" "apellidos" => "Sağlam" ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Department of Internal Medicine, Gülhane Military Medical Academy, Ankara, Turkey" "identificador" => "aff0005" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "<span class="elsevierStyleItalic">Corresponding author</span>." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Comentario a “Cellular and molecular aspects of diabetic nephropathy; the role of VEGF-A”" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">We read the published article with the title of ‘Cellular and molecular aspects of diabetic nephropathy; the role of VEGF-A’<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">1</span></a> with a great interest and we found worth sharing our clinical observations through a case to contribute to the their determination.</p><p id="par0010" class="elsevierStylePara elsevierViewall">Katherine Carranza et al.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">1</span></a> have stated that the experimental conditions VEGF-A decreased or after treatment with molecules developed against VEGF, it can be observed various pathologic processes such as glomerular basement membrane damage, proteinuria, acute renal failure and thromboembolic events. Monoclonal antibodies that bind the VEGF has long been used in systemic treatment protocol of solid tumors. Recently, by ophthalmologists, intravitreal administration of anti-VEGF agents seen as the primary treatment method in conditions of age- related macular degeneration, diabetic retinopathy, retinal vein occlusion.<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">2</span></a> Although systemic side effects are well known with the high dose intravenous use in cancer therapy, almost local side effects were reported associated with intraocular anti-VEGF treatment. However, despite the blood retinal barrier, anti-VEGF agents are detectable in systemic circulation after intraocular administration through uveal vessels or by aqueous humor outflow and might constitutes systemic adverse effect like nephropathy by antagonizing to VEGF-dependent pathway in glomeruli.<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">3</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">We describe a case of nephrotic syndrome that were unable to detect significant findings for etiology in first research. But with detailed history we found that she had received intravitreal anti-VEGF due to diabetic retinopathy 10 days before the occurrence of symptoms. After the exclusion of other possible causes. We thought anti-VEGF agents might be responsible. In the literature, we found only 3 cases associated with renal toxicity of intraocular anti-VEGF therapy.<a class="elsevierStyleCrossRefs" href="#bib0050"><span class="elsevierStyleSup">4–6</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">We would like to remind that even at the small quantities used in the practice of ophthalmology, anti-VEGF agents may able to cause serious systemic effects including nephropathy.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:6 [ 0 => array:3 [ "identificador" => "bib0035" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cellular and molecular aspects of diabetic nephropathy; the role of VEGF-A" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "K. Carranza" 1 => "D. Veron" 2 => "A. Cercado" 3 => "N. Bautista" 4 => "W. Pozo" 5 => "A. Tufro" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.nefro.2015.05.013" "Revista" => array:6 [ "tituloSerie" => "Nefrologia" "fecha" => "2015" "volumen" => "35" "paginaInicial" => "131" "paginaFinal" => "138" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26300505" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0040" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "R.F. Spaide" 1 => "Y.L. Fisher" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Retina" "fecha" => "2006" "volumen" => "26" "paginaInicial" => "275" "paginaFinal" => "278" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16508426" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0045" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Systemic adverse events after intravitreal bevacizumab versus ranibizumab for age-related macular degeneration: a meta-analysis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "W. Wang" 1 => "X. Zhang" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1371/journal.pone.0109744" "Revista" => array:5 [ "tituloSerie" => "PLOS ONE" "fecha" => "2014" "volumen" => "9" "paginaInicial" => "e109744" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25330364" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0050" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Relapse of minimal change nephrotic syndrome after intravitreal bevacizumab" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "T. Sato" 1 => "Y. Kawasaki" 2 => "T. Waragai" 3 => "T. Imaizumi" 4 => "A. Ono" 5 => "N. Sakai" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/ped.12017" "Revista" => array:6 [ "tituloSerie" => "Pediatr Int" "fecha" => "2013" "volumen" => "55" "paginaInicial" => "e46" "paginaFinal" => "e48" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23782377" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0055" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Membranous nephropathy following intravitreal injection of bevacizumab" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "H.R. Anto" 1 => "G.F. Hyman" 2 => "J.P. Li" 3 => "S. Spitalewitz" 4 => "D. Thomas" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jcjo.2011.12.024" "Revista" => array:6 [ "tituloSerie" => "Can J Ophthalmol" "fecha" => "2012" "volumen" => "47" "paginaInicial" => "84" "paginaFinal" => "86" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22333861" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0060" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Systemic and kidney toxicity of intraocular administration of vascular endothelial growth factor inhibitors" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "G. Pellé" 1 => "N. Shweke" 2 => "J.P. Duong Van Huyen" 3 => "L. Tricot" 4 => "S. Hessaïne" 5 => "V. Frémeaux-Bacchi" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1053/j.ajkd.2010.11.030" "Revista" => array:6 [ "tituloSerie" => "Am J Kidney Dis" "fecha" => "2011" "volumen" => "57" "paginaInicial" => "756" "paginaFinal" => "759" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21295897" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/02116995/0000003600000006/v1_201611240148/S0211699516301114/v1_201611240148/en/main.assets" "Apartado" => array:4 [ "identificador" => "48186" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Cartas al Director" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/02116995/0000003600000006/v1_201611240148/S0211699516301114/v1_201611240148/en/main.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699516301114?idApp=UINPBA000064" ]
| año/Mes | Html | Total | |
|---|---|---|---|
| 2024 Noviembre | 2 | 7 | 9 |
| 2024 Octubre | 33 | 37 | 70 |
| 2024 Septiembre | 39 | 22 | 61 |
| 2024 Agosto | 64 | 57 | 121 |
| 2024 Julio | 41 | 28 | 69 |
| 2024 Junio | 51 | 34 | 85 |
| 2024 Mayo | 57 | 29 | 86 |
| 2024 Abril | 41 | 36 | 77 |
| 2024 Marzo | 36 | 27 | 63 |
| 2024 Febrero | 34 | 33 | 67 |
| 2024 Enero | 30 | 30 | 60 |
| 2023 Diciembre | 33 | 21 | 54 |
| 2023 Noviembre | 52 | 27 | 79 |
| 2023 Octubre | 63 | 24 | 87 |
| 2023 Septiembre | 67 | 23 | 90 |
| 2023 Agosto | 61 | 25 | 86 |
| 2023 Julio | 63 | 20 | 83 |
| 2023 Junio | 61 | 21 | 82 |
| 2023 Mayo | 80 | 29 | 109 |
| 2023 Abril | 51 | 10 | 61 |
| 2023 Marzo | 63 | 32 | 95 |
| 2023 Febrero | 51 | 19 | 70 |
| 2023 Enero | 31 | 27 | 58 |
| 2022 Diciembre | 77 | 47 | 124 |
| 2022 Noviembre | 62 | 32 | 94 |
| 2022 Octubre | 52 | 35 | 87 |
| 2022 Septiembre | 38 | 28 | 66 |
| 2022 Agosto | 52 | 48 | 100 |
| 2022 Julio | 36 | 42 | 78 |
| 2022 Junio | 57 | 37 | 94 |
| 2022 Mayo | 42 | 27 | 69 |
| 2022 Abril | 52 | 52 | 104 |
| 2022 Marzo | 58 | 38 | 96 |
| 2022 Febrero | 34 | 51 | 85 |
| 2022 Enero | 37 | 41 | 78 |
| 2021 Diciembre | 47 | 42 | 89 |
| 2021 Noviembre | 48 | 36 | 84 |
| 2021 Octubre | 46 | 45 | 91 |
| 2021 Septiembre | 41 | 37 | 78 |
| 2021 Agosto | 31 | 43 | 74 |
| 2021 Julio | 40 | 37 | 77 |
| 2021 Junio | 33 | 32 | 65 |
| 2021 Mayo | 39 | 44 | 83 |
| 2021 Abril | 93 | 75 | 168 |
| 2021 Marzo | 70 | 40 | 110 |
| 2021 Febrero | 27 | 40 | 67 |
| 2021 Enero | 37 | 28 | 65 |
| 2020 Diciembre | 24 | 19 | 43 |
| 2020 Noviembre | 39 | 21 | 60 |
| 2020 Octubre | 27 | 40 | 67 |
| 2020 Septiembre | 22 | 17 | 39 |
| 2020 Agosto | 42 | 14 | 56 |
| 2020 Julio | 31 | 18 | 49 |
| 2020 Junio | 27 | 26 | 53 |
| 2020 Mayo | 32 | 36 | 68 |
| 2020 Abril | 25 | 25 | 50 |
| 2020 Marzo | 38 | 13 | 51 |
| 2020 Febrero | 37 | 23 | 60 |
| 2020 Enero | 36 | 17 | 53 |
| 2019 Diciembre | 36 | 37 | 73 |
| 2019 Noviembre | 30 | 30 | 60 |
| 2019 Octubre | 22 | 24 | 46 |
| 2019 Septiembre | 38 | 24 | 62 |
| 2019 Agosto | 14 | 28 | 42 |
| 2019 Julio | 21 | 21 | 42 |
| 2019 Junio | 24 | 23 | 47 |
| 2019 Mayo | 23 | 30 | 53 |
| 2019 Abril | 26 | 42 | 68 |
| 2019 Marzo | 29 | 18 | 47 |
| 2019 Febrero | 28 | 24 | 52 |
| 2019 Enero | 16 | 15 | 31 |
| 2018 Diciembre | 89 | 39 | 128 |
| 2018 Noviembre | 203 | 28 | 231 |
| 2018 Octubre | 137 | 26 | 163 |
| 2018 Septiembre | 61 | 23 | 84 |
| 2018 Agosto | 50 | 22 | 72 |
| 2018 Julio | 53 | 15 | 68 |
| 2018 Junio | 72 | 17 | 89 |
| 2018 Mayo | 68 | 13 | 81 |
| 2018 Abril | 90 | 17 | 107 |
| 2018 Marzo | 78 | 14 | 92 |
| 2018 Febrero | 63 | 10 | 73 |
| 2018 Enero | 58 | 12 | 70 |
| 2017 Diciembre | 85 | 10 | 95 |
| 2017 Noviembre | 52 | 16 | 68 |
| 2017 Octubre | 55 | 8 | 63 |
| 2017 Septiembre | 79 | 14 | 93 |
| 2017 Agosto | 86 | 9 | 95 |
| 2017 Julio | 78 | 15 | 93 |
| 2017 Junio | 50 | 9 | 59 |
| 2017 Mayo | 51 | 14 | 65 |
| 2017 Abril | 51 | 11 | 62 |
| 2017 Marzo | 39 | 25 | 64 |
| 2017 Febrero | 52 | 12 | 64 |
| 2017 Enero | 58 | 11 | 69 |
| 2016 Diciembre | 78 | 24 | 102 |
| 2016 Noviembre | 89 | 10 | 99 |
| 2016 Octubre | 98 | 17 | 115 |
| 2016 Septiembre | 78 | 7 | 85 |
| 2016 Agosto | 64 | 3 | 67 |
| 2016 Julio | 3 | 0 | 3 |
Mostrar todo
